Key result
A diagnostic quality 6-lead ECG was successfully obtained using an AliveCor smartphone-based device in a HeartMate 3 LVAD patient during an episode of sustained palpitations.
Why the study?
LVAD patients are at risk of ventricular arrhythmias, but 12-lead ECG access is predominantly in healthcare facilities and LVADs cause significant electromagnetic interference leading to ECG artefacts.
Can a smartphone-based recording device provide a diagnostic quality ECG in a patient with a HeartMate 3 LVAD despite electromagnetic interference?
Case Report (n=1)
Can a smartphone-based recording device provide a diagnostic quality ECG in a patient with a HeartMate 3 LVAD despite electromagnetic interference?
Smartphone-based ECG devices can provide diagnostic quality recordings in LVAD patients, enabling remote identification of ventricular arrhythmias despite electromagnetic interference.
Smartphone ECG yielded diagnostic tracing in HeartMate 3 patient; hypothesis-generating for remote VA detection, needs prospective validation.
Patients with implantable left ventricular assist devices (LVAD) are at risk of ventricular arrhythmias but these may be hemodynamically tolerated. An electrocardiogram (ECG) is essential to determine whether an LVAD-supported patient is experiencing a ventricular arrhythmia. Access to 12 lead ECG is predominantly in healthcare facilities. Implantable LVAD also cause significant electromagnetic interference leading to artefacts on ECG. We report a patient on Heartmate 3 LVAD with a diagnostic quality 6 lead ECG obtained with an AliveCor device during an episode of sustained palpitations. The AliveCor device may be used for remote identification of ventricular arrhythmias in LVAD patients.
No takes yet. Share an insight, caveat, or question.
Tasos et al. (2023) conducted a case report in HeartMate 3 LVAD with sustained palpitations (n=1). AliveCor smartphone-based recording device was evaluated on Diagnostic quality 6 lead ECG. A diagnostic quality 6-lead ECG was successfully obtained using an AliveCor smartphone-based device in a HeartMate 3 LVAD patient during an episode of sustained palpitations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: